We are monitoring the impact of COVID-19 on Asia Pacific Clostridium Botulinum Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6953
Share on
Share on

Asia Pacific Clostridium Botulinum Market Research Report – Segmented By Product, End-user, Distribution Channel & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 6953
Pages: 145

APAC Clostridium Botulinum Market (2020 to 2025)

The size of the Asia Pacific Clostridium Botulinum Market is predicted to be growing at a healthy rate during the forecast period.

Government support from the Asia Pacific countries in setting up healthcare infrastructures like hospitals and clinics is expected to add fuel to the market growth in this region. Adopting new non-surgical aesthetic methods, lack of cleanliness, surging number of expertise professionals performing non-surgical botulinum toxin procedures, tax advantages, and colossal government support in setting up healthcare infrastructures like hospitals research clinics are fueling the market growth over the period. Nearly 1,801,033 procedures were performed with botulinum toxin, and out of the total, 1,638,940 were females, according to the American Society for Aesthetic Plastic Surgery in 2018. FDA approvals for botulinum treatments, growing awareness, and increasing cosmetic and therapeutic procedures across the region influence market growth.

The pressuring prices related to research and development projects and the government's sternness are some obstacles that hinder market growth in the APAC region.

This market research report on the Asia Pacific Clostridium Botulinum Market has been segmented & sub-segmented into the following categories:

  • By Product Type: Botulinum Toxin Type A and Botulinum Toxin Type B      
  • By Application: Aesthetic and Therapeutics   
  • By Distribution Channel: Hospitals, Clinics, and Retail pharmacies 
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regional Analysis:

APAC is anticipated to showcase the highest growth rate with the highest share and is likely to grow in the forthcoming years. Factors like aging demographics, increasing discretionary expenses, which give outcome in the growing demand for anti-aging products. Also, rising social awareness concerning the commercial availability of products in the APAC region.

Countries like India and China are contributing a significant share of the clostridium botulinum market of this region. Factors like large population, common bacterial diseases, and favorable reimbursement policies for treatments and therapies propel this region's market growth.

The Indian market is expected to have notable growth in the market due to the growing demand for aesthetic procedures, particularly botulinum toxin. The old age people population, augmenting the number of surgeons, and the rise in facial aesthetic procedures add fuel to the Clostridium botulinum market growth during the analysis period.

The Japanese market is expected to have considerable growth in the upcoming years due to the substitution of non-surgical procedures and escalating healthcare expenses in appearing markets. In China, facial neuropathy is increasing by around 0.003%, which is commonly seen in women. Moreover, escalating research and development practices and obtaining efficacy solutions for botulism promote the region's clostridium market growth.

Some of the top players operating in the Asia Pacific clostridium botulinum infection market are XOMA Ltd., AlphaVax, Inc., Cangene Corporation, Morphotek, Inc., DynPort Vaccine Company LLC, Emergent BioSolutions, Inc., Molecular Targeting Technologies, Inc., and many others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Botulinum toxin type A      

                                5.1.3 Botulinum toxin type B      

                                5.1.4  Y-o-Y Growth Analysis, By Product              

                                5.1.5  Market Attractiveness Analysis, By Product            

                                5.1.6  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Aesthetic 

                                5.2.3 Therapeutics          

                                5.2.4 Y-o-Y Growth Analysis, By application         

                                5.2.5 Market Attractiveness Analysis, By application       

                                5.2.6 Market Share Analysis, By application         

                5.3 Distribution channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Retail pharmacies 

                                5.3.5 Y-o-Y Growth Analysis, By distribution channel       

                                5.3.6  Market Attractiveness Analysis, By distribution channel    

                                5.3.7  Market Share Analysis, By distribution channel      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By application

                                                6.1.3.4 By distribution channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By application

                                                6.1.4.4 By distribution channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By application

                                                6.1.5.4 By distribution channel

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DynPort Vaccine Company                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Emergent BioSolutions, Inc.                

                8.3 XOMA Ltd.                  

                8.4 AlphaVax                     

                8.5 Cangene Corporation                             

                8.6 Morphotek, Inc.                       

                8.7 Morphotek, Inc.                       

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product, Type  with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  2. Asia Pacific Botulinum toxin type A Market, By Region, From 2020 to 2025 (USD Million)
  3. Asia Pacific Botulinum toxin type B Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia Pacific Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  5. Asia Pacific Aesthetic Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia Pacific Therapeutics Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia Pacific Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  8. Asia Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  9. Asia Pacific Clinics Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia Pacific Retail pharmacies Market, By Region, From 2020 to 2025 (USD Million)
  11. Japan Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  12. Japan Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  13. Japan Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  14. China Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  15. China Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  16. China Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  17. India Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  18. India Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  19. India Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  20. Australia Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  21. Australia Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  22. Australia Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  23. South Korea Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  24. South Korea Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  25. South Korea Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample